Alimera Sciences Inc logo

Alimera Sciences Inc

NAS:ALIM (USA)  
$ 3.16 -0.005 (-0.16%) 03:01 PM EST
At Loss
P/B:
4.04
Market Cap:
$ 165.29M
Enterprise V:
$ 221.15M
Volume:
27.91K
Avg Vol (2M):
60.98K
Also Trade In:
Volume:
27.91K
At Loss
Avg Vol (2M):
60.98K

Business Description

Description
Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East operations are managed as three operating segments: U.S., International and Operating Cost It generates maximum revenue from U.S. Segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.21
Equity-to-Asset 0.27
Debt-to-Equity 1.71
Debt-to-EBITDA 34.05
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.35
Distress
Grey
Safe
Beneish M-Score -0.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.41
9-Day RSI 34.12
14-Day RSI 37.99
6-1 Month Momentum % -2.34
12-1 Month Momentum % 45.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.62
Quick Ratio 2.51
Cash Ratio 0.69
Days Inventory 48.71
Days Sales Outstanding 116.3
Days Payable 254.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -109.2
Shareholder Yield % -14.45

Financials (Next Earnings Date:2024-08-09 Est.)

ALIM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALIM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Alimera Sciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 90.219
EPS (TTM) ($) -1.572
Beta 0.72
Volatility % 68.74
14-Day RSI 37.99
14-Day ATR ($) 0.260408
20-Day SMA ($) 3.47675
12-1 Month Momentum % 45.22
52-Week Range ($) 2.27 - 4.38
Shares Outstanding (Mil) 52.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alimera Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Alimera Sciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Alimera Sciences Inc Frequently Asked Questions

What is Alimera Sciences Inc(ALIM)'s stock price today?
The current price of ALIM is $3.16. The 52 week high of ALIM is $4.38 and 52 week low is $2.27.
When is next earnings date of Alimera Sciences Inc(ALIM)?
The next earnings date of Alimera Sciences Inc(ALIM) is 2024-08-09 Est..
Does Alimera Sciences Inc(ALIM) pay dividends? If so, how much?
Alimera Sciences Inc(ALIM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1